Humacyte Expands Board Expertise with Appointment of Scott Coward and Paul Kuznik
Humacyte added life science veterans Scott Coward and Paul Kuznik to its Board of Directors. Coward, formerly EVP and Chief Legal Officer at Exact Sciences, joins the Audit Committee, while Kuznik, a three-decade vascular and cardiovascular medtech executive including leadership of Terumo Aortic, joins the Commercial Committee. The appointments come as Humacyte scales the Symvess launch and prepares for a planned U.S.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.